The Journal of Cystic Fibrosis published an article titled – Role of Tris-CaEDTA as an adjuvant with nebulised tobramycin in cystic fibrosis patients with Pseudomonas aeruginosa lung infections: A randomised clinical trial – on 16 December 2020. Click here to read the article.
